Premature birth and disability

NEW YORK, Aug 10 (Praxis Press) Small studies have shown that many children born as extremely preterm infants suffer from neurologic and developmental disabilities, but confirmation by a large-scale study has been lacking. To address this issue, Wood and colleagues conducted a prospective study of all infants born at 20 through 25 completed weeks of gestation in the United Kingdom and Ireland during a 10-month period beginning in March 1995. They measured development, neurologic function, and oc

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, Aug 10 (Praxis Press) Small studies have shown that many children born as extremely preterm infants suffer from neurologic and developmental disabilities, but confirmation by a large-scale study has been lacking. To address this issue, Wood and colleagues conducted a prospective study of all infants born at 20 through 25 completed weeks of gestation in the United Kingdom and Ireland during a 10-month period beginning in March 1995. They measured development, neurologic function, and occurrence of disability in these children. They found that of 308 surviving children who had been formally assessed, 19% had severely delayed development and 49% had disability overall; almost half the children with disability met the criteria for severe disability. This is the first large-scale study to confirm that severe disability is common among children born as extremely preterm infants.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform